GC Biopharma breaks ground on blood product plant in Indonesia
South Korea’s GC Biopharma Corp. broke ground on Wednesday on Indonesia’s first blood product plant through technology transfer.Indonesi...
SK Plasma gets investment from Indonesian fund
South Korea’s SK Plasma on Tuesday said it signed a term sheet, or a nonbinding agreement on the basic terms and conditions of an investment, ...
Plasmapp to export 12.3 mn worth of sterilizers to Japan
South Korea's bioplasma technology firm Plasmapp announced on Friday that it has signed a product supply contract worth 16.4 billion won ($12.3 mill...
SK Plasma to supply $30 mn in blood products to Singapore
South Korea's SK Plasma on Wednesday announced the launch of full-scale production this month of the blood products albumin and immunoglobulin for S...
Curexo, Kyocera to enter Japan’s artificial joint surgery robot market
South Korea's medical robot company Curexo partnered with Kyocera Corporation to enter the Japanese market for artificial joint surgery robots.Curex...
Curexo unveils artificial joint surgery robot TMAX at AAOS 2023
Curexo, a South Korean medical robot company, said on Tuesday that it had unveiled its artificial joint surgery robot "TMAX" at AAOS 2023, the world...
SK Plasma to build blood products plant in Indonesia
South Korea’s SK Plasma will build a blood products plant in Indonesia.Industry sources on Tuesday said the company recently received approval...
SK Plasma, Janssen Korea sign sales, distribution agreement
SK Plasma Co. Ltd., a South Korean company specializing in the production of plasma derivatives from human plasma, is expanding its product portfoli...
Plasmapp, Curexo agree on joint development of surgical robot solutions
South Korea's bioplasma technology firm Plasmapp said on Friday that it signed a memorandum of understanding with Curexo, a domestic medical robot m...
SK Discovery to control affiliates’ entire biotechnology business
SK Discovery Co., an intermediate holding company of South Korea’s third-largest conglomerate SK Group, will take charge of the entire biotech...
TiumBio acquires stake in SK Plasma to beef up R&D for rare diseases
South Korea-based biopharmaceutical company TiumBio is set to acquire 30 billion won ($26 million) worth of shares in SK Plasma, a blood product com...
